SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis

by Jacobs RT, Nare B, Wring SA, Orr MD, Chen D, Sligar JM, Jenks MX, Noe RA, Bowling TS, Mercer LT, Rewerts C, Gaukel E, Owens J, Parham R, Randolph R, Beaudet B, Bacchi CJ, Yarlett N, Plattner JJ, Freund Y, Ding C, Akama T, Zhang Y-K, Brun R, Kaiser M, Scandale I, Don R. PLoS Negl Trop Dis, June 2011, e1151.

Click here to read the article  / PDF